Literature DB >> 6342408

The Berkeley Orthokeratology Study, Part II: Efficacy and duration.

K A Polse, R J Brand, J S Schwalbe, D W Vastine, R J Keener.   

Abstract

Relative efficacy of orthokeratology (OK) was evaluated by assessing changes in refractive error, visual acuity, and corneal curvature in 31 treated and 28 randomized control subjects who wore conventional rigid contact lenses. The duration of changes was studied by monitoring subjects after lens wear was discontinued. After an average of 444 days of contact lens wear the treatment group showed an overall mean reduction in spherical equivalent refractive error of 1.01 D compared with 0.54 D in the control group (p = 0.02). Both groups had considerable variation in refractive error change. Corresponding mean improvements in unaided visual acuity were -0.27 and -0.20 log of the minimum angle of resolution [log (MAR)]. Corneal curvature decreased in both comparison groups, but the actual diopter value was about one-half that of the refractive change. The changes in these characteristics tended to occur during the first 132 days of wear, and additional aggressive lens therapy during the remaining 241 days of treatment produced little additional change. The refractive error fluctuated considerably during the period of follow-up and these fluctuations tended to be larger in those subjects who had shown greater changes in refractive error. When the lenses were removed, ocular characteristics returned steadily toward baseline levels. Ninety-five days after discontinuing lens wear, the refractive error had returned 75 and 69% of the way to baseline levels for the treatment and control groups, respectively. Visual acuity and corneal curvature showed similar rebound after 95 days. We conclude that it is possible to reduce myopia about 1D; however, the change is not permanent. Results indicate that the level of vision during periods of nonlens wear would be unstable, making it difficult to predict what the quality of vision would be under a retainer lens wear program.

Entities:  

Mesh:

Year:  1983        PMID: 6342408     DOI: 10.1097/00006324-198303000-00006

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  8 in total

Review 1.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina Lindsley; Satyanarayana S Vedula; Susan A Cotter; Donald O Mutti; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina B Lindsley; S Swaroop Vedula; Susan A Cotter; Donald O Mutti; Sueko M Ng; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2020-01-13

3.  The control effect of orthokeratology on axial length elongation in Chinese children with myopia.

Authors:  Meng-Jun Zhu; Hao-Yan Feng; Xian-Gui He; Hai-Dong Zou; Jian-Feng Zhu
Journal:  BMC Ophthalmol       Date:  2014-11-24       Impact factor: 2.209

Review 4.  Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia.

Authors:  Sangeethabalasri Pugazhendhi; Balamurali Ambati; Allan A Hunter
Journal:  Clin Ophthalmol       Date:  2020-03-18

Review 5.  Update in pediatric myopia treatment strategies.

Authors:  Silvia Țone; Irina Andreea Niagu; Ștefan Tudor Bogdănici; Camelia Margareta Bogdănici
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep

6.  Sustainability of orthokeratology as demonstrated by corneal topography.

Authors:  Sung Yong Kang; Bong Kyun Kim; Young Ja Byun
Journal:  Korean J Ophthalmol       Date:  2007-06

Review 7.  Efficacy and Acceptability of Orthokeratology for Slowing Myopic Progression in Children: A Systematic Review and Meta-Analysis.

Authors:  Daizong Wen; Jinhai Huang; Hao Chen; Fangjun Bao; Giacomo Savini; Antonio Calossi; Haisi Chen; Xuexi Li; Qinmei Wang
Journal:  J Ophthalmol       Date:  2015-06-11       Impact factor: 1.909

Review 8.  Orthokeratology in Moderate Myopia: A Study of Predictability and Safety.

Authors:  Kirti Singh; Mainak Bhattacharyya; Abhishek Goel; Ritu Arora; Nikhil Gotmare; Himshikha Aggarwal
Journal:  J Ophthalmic Vis Res       Date:  2020-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.